XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Performance Share Units
Restricted Stock Units
Treasury Shares
Treasury Shares
Performance Share Units
Treasury Shares
Restricted Stock Units
Common stock
Common stock
Performance Share Units
Common stock
Restricted Stock Units
Preferred Shares Issued
Additional Paid-In Capital
Additional Paid-In Capital
Performance Share Units
Additional Paid-In Capital
Restricted Stock Units
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Shares, beginning balance (in shares) at Dec. 31, 2020       (15,680,000)                      
Common Shares Issued, beginning balance (in shares) at Dec. 31, 2020             46,817,000                
Preferred Shares Issued, beginning balance (in shares) at Dec. 31, 2020                   10,000          
Beginning balance at Dec. 31, 2020 $ 449,262     $ (225,506)     $ 468     $ 0 $ 103,445     $ 567,512 $ 3,343
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Vesting of equity instruments other than options (in shares)         (16,000) [1] (53,000) [1]   62,000 208,000            
Vesting of equity instruments other than options   $ (241) $ (815)   $ (241) $ (815)     $ 2       $ (2)    
Retirement of treasury shares (in shares)       (69,000) [1]     (69,000)                
Retirement of treasury shares 0     $ 1,056             (1,056)        
Purchases of treasury stock (in shares)       (117,000)                      
Purchases of treasury stock (1,609)     $ (1,609)                      
Share-based compensation 5,815                   5,815        
Net income (loss) 20,407                         20,407  
Other comprehensive income (loss), net of taxes (18,911)                           (18,911)
Declaration of dividends (24,206)                         (24,206)  
Treasury Shares, ending balance (in shares) at Dec. 31, 2021       (15,797,000)                      
Common Shares Issued, beginning balance (in shares) at Dec. 31, 2021             47,018,000                
Preferred Shares Issued, ending balance (in shares) at Dec. 31, 2021                   10,000          
Ending balance at Dec. 31, 2021 429,702     $ (227,115)     $ 470     $ 0 108,202     563,713 (15,568)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Vesting of equity instruments other than options (in shares)         (9,000) [1] (27,000) [1]   33,000 111,000            
Vesting of equity instruments other than options   (104) (314)   $ (104) $ (314)   $ 1 $ 1     $ (1) $ (1)    
Grants of restricted stock awards (in shares)             53,000                
Grants of restricted stock awards 0                            
Retirement of treasury shares (in shares)       (36,000) [1]     (36,000)                
Retirement of treasury shares 0     $ 418             (418)        
Purchases of treasury stock (in shares)       (993,000)                      
Purchases of treasury stock (11,643)     $ (11,643)                      
Share-based compensation 4,727                   4,727        
Net income (loss) (22,257)                         (22,257)  
Other comprehensive income (loss), net of taxes (88,214)                           (88,214)
Declaration of dividends $ (24,001)                         (24,001)  
Treasury Shares, ending balance (in shares) at Dec. 31, 2022 (16,790,000)     (16,790,000)                      
Common Shares Issued, beginning balance (in shares) at Dec. 31, 2022 47,179,000           47,179,000                
Preferred Shares Issued, ending balance (in shares) at Dec. 31, 2022 10,000                 10,000          
Ending balance at Dec. 31, 2022 $ 287,896     $ (238,758)     $ 472     $ 0 112,509     517,455 (103,782)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Vesting of equity instruments other than options (in shares)         (6,000) [1] (16,000) [1]   16,000 48,000            
Vesting of equity instruments other than options   $ (64) $ (160)   $ (64) $ (160)                  
Stock option exercises, shares (in shares)       (82,000) [1]     94,000                
Grants of restricted stock awards (in shares)             36,000                
Grants of restricted stock awards 0                            
Stock option exercises 1,276     $ (115)             1,391        
Retirement of treasury shares (in shares)       (104,000) [1]     (104,000)                
Retirement of treasury shares (1,391)     $ 339             (1,730)        
Purchases of treasury stock (in shares)       (1,513,000)                      
Purchases of treasury stock (22,021)     $ (22,021)                      
Share-based compensation 5,006                   5,006        
Other [2] (2,090)                   (2,090)        
Net income (loss) 66,823                         66,823  
Other comprehensive income (loss), net of taxes 29,610                           29,610
Declaration of dividends $ (23,588)                         (23,588)  
Treasury Shares, ending balance (in shares) at Dec. 31, 2023 (18,303,000)     (18,303,000)                      
Common Shares Issued, beginning balance (in shares) at Dec. 31, 2023 47,269,000           47,269,000                
Preferred Shares Issued, ending balance (in shares) at Dec. 31, 2023 10,000                 10,000          
Ending balance at Dec. 31, 2023 $ 341,297     $ (260,779)     $ 472     $ 0 $ 115,086     $ 560,690 $ (74,172)
[1] All shares acquired represent shares tendered to cover the strike price for options and tax withholdings on the intrinsic value of stock options exercised, restricted stock vested, performance share units vested, or restricted stock units vested. These shares have been cancelled by the Company.
[2]
The Other line within Paid-in Capital includes $2.1 million in connection with the cash settlement of certain restricted stock units.